FMI
HAE icon

F/M Investments’s Haemonetics HAE Stock Holding History

F/M Investments’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-51,500
Closed -$2.51M – 443
2025
Q3 		$2.51M Sell
51,500
-381
-0.7% -$23.6K 0.1% 213
2025
Q2 		$3.87M Buy
51,881
+127
+0.2% +$8.41K 0.14% 158
2025
Q1 		$3.29M Sell
51,754
-585
-1% -$39.8K 0.13% 164
2024
Q4 		$4.09M Sell
52,339
-50,133
-49% -$4.03M 0.15% 143
2024
Q3 		$8.24M Buy
+102,472
New +$8.28M 0.26% 128

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

F/M Investments's HAE Position: Q4 2025 in Review

F/M Investments sold out of Haemonetics (HAE) in Q4 2025, closing a stake of 51,500 shares — an estimated $2.51M sold.

F/M Investments first reported a position in HAE in Q3 2024 and held it in 5 quarters. The position peaked at $8.24M in Q3 2024. 329 funds tracked by Wall St. Rank hold HAE as of Q4 2025.

  • F/M Investments reported no remaining Haemonetics position as of Q4 2025 after selling out during the quarter.
  • F/M Investments sold 51,500 Haemonetics shares in Q4 2025, an estimated $2.51M.
  • F/M Investments first reported a position in Haemonetics in Q3 2024 and held it in 5 quarters.
  • F/M Investments's Haemonetics position peaked at $8.24M in Q3 2024.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q4 2025.

Based on F/M Investments's 13F filing for Q4 2025, filed 3 Feb 2026.